Special Issue "Leukocytes in Inflammation, Resolution of Inflammation, Autoimmune Diseases and Cancer—Series 2"
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Immunology".
Deadline for manuscript submissions: 15 December 2023 | Viewed by 1910
Special Issue Editor
Interests: innate immunity; inflammation; resolution of inflammation; leukocytes; endothelial cells; apoptosis; formyl peptide receptors; toll-like receptors; lipid mediators; acute-phase proteins; intracellular signaling; sepsis; ARDS; acute coronary artery disease
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Acute inflammation is a protective, self-limited mechanism to eliminate invading pathogens and restore homeostasis. Uncontrolled or non-resolving inflammation is a prominent component of many common diseases such as cardiovascular, pulmonary, immune and neurodegenerative diseases, metabolic syndromes, diabetes, and cancer. Since the inflammatory response is critical for survival, the current anti-inflammatory therapies have limitations and often do not lead to repair of affected tissues. Hence, it is critical to appreciate mechanism that control the inflammatory reactions and orchestrate the resolution. Advanced techniques, such as intravital microscopy, single cell sequencing, genetic fate mapping and metabolomics, have driven considerable research in the field, spawning studies into more complex interactions.
This Special Issue will address inflammatory cell heterogeneity and fate within the inflammatory locus and characterize novel mechanisms (for example, NETosis, reverse migration, transcriptional burst, efferocytosis, microbiota regulation of leukocyte functions) that shape the diverse roles of leukocyte subsets in acute and chronic inflammatory conditions with an emphasis how these mechanisms can be harnessed for development of novel therapeutic approaches.
Prof. Dr. János G. Filep
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neutrophil heterogeneity
- macrophage subsets
- NET formation
- inflammation
- resolution of inflammation
- adaptive immunity
- cardiovascular and pulmonary diseases
- neurodegenerative diseases
- autoimmune diseases
- cancer